LeukoScan monoclonal antibody fragment labeled with technetium-99m data

IMMU reported Phase III data from one of the 14 sites participating, showing equivalence with indium-111 imaging of white blood cells.

As presented at the meeting of the Society of Nuclear Medicine in Minneapolis, the technique had sensitivity, specificity, and accuracy in each of three arms of the trial that were at least as good as the indium imaging method, which requires scanning 24 to 48 hours after labeling a patient's white cells. The LeukoScan technique can be performed eight hours after injecting the antibody directly. ...